Conference Coverage
Latest News
Three Conditions for Which Cannabis Appears to Help
Neuropathic pain, chemotherapy-induced nausea or vomiting, and spasticity in people with multiple sclerosis, may be helped by cannabis.
Conference Coverage
Could Bedside Training Help End the US Neurologist Shortage?
As internal medicine providers are often “the first to lay eyes” on patients with a neurology complaint, it’s important they “have a basic level...
Conference Coverage
Teleneurology for Suspected Stroke Speeds Treatment
“What we’re proposing as a best practice is not only should the ED or ED provider be aware, but there needs to be a system in place for...
Conference Coverage
Novel Agent Curbs Alzheimer’s-Related Agitation
More than half of participants in the open-label extension period of the randomized clinical trial responded to the medication, which was...
Conference Coverage
Approved Therapy for ALS Is Withdrawn When New Study Shows No Benefit
A newly completed trial has led to market withdrawal of the ALS therapy PB&TURSO.
Conference Coverage
Positive Results From Phase 2 Trial Support Potential New Option for Control of CIDP
Efgartigimod PC20 trial meets the primary endpoint with favorable safety profile.
Conference Coverage
Pediatric Patients With MS May Do Best on High-Efficacy DMTs
Conference Coverage
Lidocaine Nerve Block Effective for Severe, Refractory Migraine in Children
“This is the first randomized controlled trial that shows lidocaine injections can be significantly more effective than a placebo for these...
Conference Coverage
New and Improved Option for Detecting Neurologic Pathogens?
Metagenomic next-generation sequencing (mNGS) of RNA and DNA from cerebrospinal fluid can simultaneously test for a wide range of infectious...
Conference Coverage
Vaporized Cannabis for Acute Migraine Yields Rapid, Sustained Relief
“In this single-center randomized controlled trial across 247 treated migraine attacks, four puffs of vaporized THC-CBD mix were efficacious for...
Conference Coverage
IV Ketamine Promising for Severe Refractory Headache in Children
Overall, the treatment was “safe and well tolerated.”